Components of altered metabolic lipid pathways that could function as potential prognostic biomarkers or therapeutic targets to prevent the growth of cancer cells or to overcome chemotherapy resistance include cholesterol [106], fatty acid synthase [114–117], autotaxin [96] ceramide [118], and CERT [108]. This evidence concerns the gene FASN and cancer.